Skip to main content

Table 2 Demographic and clinical characteristics of study groups defined by WC

From: Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health

Variables Group 1 Group 2 Group 3
DM-AOb- DM + AOb- DM + AOb+
Age (years) 59.2 ± 12.4 65.1 ± 8.9* 62.0 ± 8.7
BMI (kg/m2) 24.9 ± 2.2 26.8 ± 4.1 33.1 ± 4.8*
Hypertension 10.9% 59.7%* 67.6%*
Smoker 8.7% 20.9%* 16.2%
Aspirin use 5.9% 49.3%* 41.9%*
Insulin use 0.0% 26.9%* 39.2%*
Metformin use 0.0% 74.6%* 74.3%*
ACEI/ARB use 16.7% 59.7%* 67.6%*
CC Blocker use 0.0% 35.8%* 36.8%*
Beta blocker use 15.2% 44.8%* 50%*
Statin use 13.8% 64.2%* 62.2%*
Fasting plasma glucose(mg/dl) 93.5 ± 9.9 148.3 ± 44.5* 166.0 ± 57.6*
HbA1C (%) 5.9 ± 0.4 7.5 ± 1.6* 8.2 ± 1.6*
Low density lipoprotein cholesterol (mg/dl) 119.8 ± 31.1 89.1 ± 27.6* 94.5 ± 31.4*
High density lipoprotein cholesterol (mg/dl) 53.6 ± 12.0 46.4 ± 11.1* 44.6 ± 12.4*
Triglycerides (mg/dl) 121.0 ± 59.9 156.5 ± 108.5* 156.6 ± 105.2*
C-reactive protein (mg/dl) 0.3 ± 0.3 0.5 ± 0.5 0.9 ± 1.5*
HOMA-IR 2.0 ± 1.1 6.03 ± 12.3* 10.8 ± 17.8*
Creatinine (mg/dl) 0.9 ± 0.2 1.0 ± 0.4 1.1 ±0.7*
Systolic blood pressure (mmHg) 119.2 ± 13.9 134.0 ± 18.6* 153.3 ± 20.6*
Diastolic blood pressure (mmHg) 67.2 ± 8.6 73.1 ± 9.7 78.4 ± 10.3*
AI (%) 29.2 ± 9.4 34.0 ± 8.9* 38.8 ± 10.4*
PWV(m/sec) 6.0 ± 0.9 6.9 ± 1.8* 7.9 ± 3.5*
  1. By-group comparisons made using one way analysis of variance (ANOVA).
  2. simultaneously comparing all three groups.
  3. *p-value vs. group 1 (significant at the 0.05 level).